| Product Code: ETC6274431 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The peripheral arterial disease (PAD) market in Bahrain is growing due to the increasing prevalence of risk factors such as diabetes, hypertension, and smoking. PAD, which involves the narrowing or blockage of the arteries that supply blood to the limbs, can lead to serious complications if left untreated. With the rise in lifestyle-related diseases and an aging population, the demand for PAD treatments, including medications, stent placements, and vascular surgeries, is rising in Bahrain. The market for PAD treatments is expected to continue growing as Bahrain`s healthcare providers adopt more advanced diagnostic tools and therapeutic interventions.
The peripheral arterial disease (PAD) market in Bahrain is expanding due to a rise in diabetes, smoking, and sedentary lifestyles. Increased screening and vascular imaging have led to higher diagnosis rates. Preventive strategies, including patient education on lifestyle modifications and pharmacotherapy with antiplatelets and statins, are being adopted widely. Multidisciplinary care involving cardiologists, vascular surgeons, and endocrinologists is shaping treatment pathways.
Bahrain`s peripheral arterial disease (PAD) market is challenged by a lack of early screening protocols, leading to late-stage diagnosis and increased risk of complications. Smoking, diabetes, and sedentary lifestyles contribute to disease prevalence, yet public awareness remains low. Treatment options like angioplasty or stenting are available in limited facilities, often requiring referrals to tertiary hospitals. Insurance coverage may not fully reimburse advanced interventions, limiting patient access.
Bahrains aging population and lifestyle diseases drive demand for peripheral arterial disease treatment. Investment opportunities lie in diagnostic imaging centers, vascular surgery units, and minimally invasive intervention devices that improve circulation and patient outcomes.
Bahrains cardiovascular health initiatives address peripheral arterial disease (PAD) through national screening programs and access to lifestyle interventions and medications. Policies encourage early detection and comprehensive vascular assessments in high-risk populations, especially diabetics. Treatment access is subsidized in public hospitals to ensure equitable care.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Peripheral Arterial Disease Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Peripheral Arterial Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Bahrain Peripheral Arterial Disease Market - Industry Life Cycle |
3.4 Bahrain Peripheral Arterial Disease Market - Porter's Five Forces |
3.5 Bahrain Peripheral Arterial Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Bahrain Peripheral Arterial Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Bahrain Peripheral Arterial Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.8 Bahrain Peripheral Arterial Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Bahrain Peripheral Arterial Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as diabetes, hypertension, and obesity leading to a higher incidence of peripheral arterial disease in Bahrain. |
4.2.2 Growing adoption of minimally invasive procedures for the treatment of peripheral arterial disease, driving market growth. |
4.2.3 Rising awareness about peripheral arterial disease and advancements in diagnostic technologies leading to early detection and treatment. |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in Bahrain impacting the accessibility and affordability of peripheral arterial disease treatments. |
4.3.2 Stringent regulatory requirements and approval processes for new medical devices and treatments hindering market growth. |
4.3.3 Economic uncertainties and fluctuations affecting healthcare spending and investment in peripheral arterial disease management in Bahrain. |
5 Bahrain Peripheral Arterial Disease Market Trends |
6 Bahrain Peripheral Arterial Disease Market, By Types |
6.1 Bahrain Peripheral Arterial Disease Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Devices, 2021- 2031F |
6.1.4 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Catheters, 2021- 2031F |
6.1.5 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.6 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Bahrain Peripheral Arterial Disease Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Bahrain Peripheral Arterial Disease Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Bahrain Peripheral Arterial Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Bahrain Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 Bahrain Peripheral Arterial Disease Market Import-Export Trade Statistics |
7.1 Bahrain Peripheral Arterial Disease Market Export to Major Countries |
7.2 Bahrain Peripheral Arterial Disease Market Imports from Major Countries |
8 Bahrain Peripheral Arterial Disease Market Key Performance Indicators |
8.1 Average age at diagnosis of peripheral arterial disease in Bahrain. |
8.2 Number of peripheral arterial disease screening programs implemented in healthcare facilities. |
8.3 Percentage of patients with peripheral arterial disease receiving appropriate treatment according to guidelines. |
8.4 Rate of adoption of minimally invasive procedures for peripheral arterial disease treatment. |
8.5 Patient satisfaction scores related to the quality of care and treatment outcomes for peripheral arterial disease. |
9 Bahrain Peripheral Arterial Disease Market - Opportunity Assessment |
9.1 Bahrain Peripheral Arterial Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Bahrain Peripheral Arterial Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Bahrain Peripheral Arterial Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.4 Bahrain Peripheral Arterial Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Bahrain Peripheral Arterial Disease Market - Competitive Landscape |
10.1 Bahrain Peripheral Arterial Disease Market Revenue Share, By Companies, 2024 |
10.2 Bahrain Peripheral Arterial Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |